Weight loss injection beginning with R: what people are searching for and what's actually licensed

Rybelsus is semaglutide in tablet form, licensed for type 2 diabetes, the same active ingredient as Wegovy, but at different doses and for a different purpose; it is not approved for weight loss in the UK.
Both UK-licensed weight loss injections start with a low dose and are titrated upward by a prescriber over several weeks, letting your body adjust gradually before reaching a maintenance dose.
Mounjaro and Wegovy are prescription-only medicines, a qualified prescriber must assess your health, BMI and medical history before any treatment can begin; eligibility is a clinical decision, not an automatic process.
Counterfeit weight loss pens circulate online, the MHRA has warned repeatedly about fake pens sold without proper clinical oversight; the safest route is a GPhC-registered UK pharmacy with a transparent supply chain.

When people search for a weight loss injection beginning with R, they're usually thinking of Rybelsus — or they've heard the name somewhere and aren't sure what it is. Here's the short answer: Rybelsus is a tablet, not an injection, and it's licensed in the UK for type 2 diabetes, not weight management. The licensed injections for weight loss in the UK are Mounjaro (tirzepatide) and Wegovy (semaglutide), both prescription-only medicines that require a clinical assessment before a prescriber can authorise them.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The injections that actually exist for weight loss in the UK, and where Rybelsus fits in

You searched for an injection beginning with R, here's what most people mean

Imagine you've been scrolling through a forum or overheard a conversation at the gym. Someone mentioned a weight loss jab beginning with R. You type it into a search bar and get a wall of results, some confident, some contradictory. It's a reasonable thing to feel confused about.

Rybelsus is the name most people land on. It does contain semaglutide (the same active ingredient found in Wegovy) and semaglutide is genuinely effective for weight loss in clinical trials. But Rybelsus is licensed by the MHRA for type 2 diabetes management, at doses of 3mg, 7mg and 14mg daily. Those are entirely different dose levels from the Wegovy weight-loss tablet schedule (which runs from 1.5mg up to 25mg and only received UK approval for weight management in June 2026). More importantly, Rybelsus is a tablet, not an injection. So if your search was for an injection specifically, Rybelsus isn't the answer on either count. The NHS's information on semaglutide sets this out clearly and is worth reading if you want to understand how the two products differ.

Sometimes people also search for Saxenda, a liraglutide injection that begins with S, or Ozempic, another semaglutide injection beginning with O that is licensed for diabetes, not weight loss. If you want a full picture of which injections are actually approved for weight management in the UK, that page covers the options without the noise.

What the two licensed weight loss injections are, and how they differ

The two injections licensed for weight management in the UK are Mounjaro and Wegovy. Both are once-weekly subcutaneous injections; both are prescription-only.

Mounjaro (tirzepatide) works on two gut-hormone receptors simultaneously (GIP and GLP-1) which makes it the only dual-agonist weight-loss medicine currently available in the UK. Treatment starts at 2.5mg. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average weight reductions of around 20–21% at the highest dose over 72 weeks. If you're curious about weight loss injections beginning with T, tirzepatide is the relevant name there.

Wegovy (semaglutide) is a single-pathway GLP-1 receptor agonist. The standard titration runs from 0.25mg up to a 2.4mg maintenance dose; the MHRA also approved a 7.2mg dose in January 2026, with a dedicated single-dose pen following in April 2026. STEP 1 trial data showed roughly 15% average weight loss over 68 weeks at 2.4mg. For more background on how weight loss injections work as a category, that page gives a broader overview.

There are practical differences beyond the trial numbers. Mounjaro uses a dual-receptor mechanism; Wegovy acts on one. The dose escalation schedules differ. Which suits a given person depends on their medical history, any existing conditions and what a prescriber determines is clinically appropriate, it genuinely isn't a decision to make from a forum post.

Eligibility, safety and what the prescription process actually involves

Both medicines are licensed for adults with a BMI of 30 or above, or 27 or above when a weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea is present. Lower thresholds can apply for some ethnic backgrounds under UK guidance. Neither medicine is licensed for people under 18, and both are not recommended during pregnancy, while breastfeeding or when actively trying to conceive.

Common side effects with both treatments follow a broadly gastrointestinal pattern: nausea, loose stools, constipation, reflux, and sometimes fatigue or headache, particularly after starting or when a dose goes up. These often ease as the body adjusts. If you develop severe, persistent stomach pain that radiates towards your back, get medical help promptly, the MHRA highlighted acute pancreatitis as a known, if infrequent, risk in a safety update in early 2026. You can report any suspected side effects through the MHRA's Yellow Card scheme.

For Mounjaro specifically, women taking oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after any dose increase, because pill absorption may be reduced. That's a detail worth raising at consultation, it's the kind of thing a prescriber catches that a self-directed internet search often misses. Worth knowing before you start, not after.

When it comes to buying safely, the process of getting a weight loss injection through a legitimate UK route always involves a proper clinical assessment. Pens offered online without that step are a serious safety risk, the MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines, worth around £45 million, and found counterfeit tirzepatide in at least one UK manufacturing raid. Any pharmacy dispensing these medicines should be verifiable on the GPhC register.

Cost, the NHS, and what a private route looks like

NHS access to both injections exists but remains limited. Tirzepatide is being phased in through GP practices from 2025, with eligibility currently tied to high BMI and multiple weight-related conditions. Wegovy is available via specialist weight management services, though waiting lists vary widely. For a clear picture of weight management treatment options more broadly, that page sets out what's available and through which route.

Private treatment costs more than nothing, and it's worth understanding what a legitimate price should include. Any provider quoting a headline figure for these medicines should be bundling in the clinical consultation, the prescription, and ideally aftercare, separate fees for those are common and worth checking. You can see what a full private weight loss treatment through our prescribers covers and judge for yourself whether it makes sense for your situation. If you're curious about tanning injections and their unproven claims, that page explains why they're a different matter entirely from licensed weight-loss medicines.

Treatment starts with a free consultation, your answers go to a real prescriber, not an algorithm, on the same day. If you'd like to understand more about who reviews consultations at nume, our clinical team page is there. If you're based in the area and want to explore your options locally, you can find out more about weight loss injections in Stoke-on-Trent and whether treatment might be right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions